Novel Modifications of Nonribosomal Peptides from Brevibacillus Laterosporus MG64 and Investigation of Their Mode of Action

Zhibo Li,Reinder H. de Vries,Parichita Chakraborty,Chunxu Song,Xinghong Zhao,Dirk-Jan Scheffers,Gerard Roelfes,Oscar P. Kuipers
DOI: https://doi.org/10.1128/aem.01981-20
2020-01-01
Applied and Environmental Microbiology
Abstract:NRPs form a class of secondary metabolites with biocontrol and pharmaceutical potential. This work describes the identification of novel bogorol variants and succinylated bogorols (namely, succilins) and further investigates their biosynthetic pathway and mode of action. Adenylation domain-mediated lipoinitiation of bogorols represents a novel pathway by which NRPs incorporate fatty acid tails. This pathway provides the possibility to engineer the lipid tail of NRPs without identifying a fatty acid coenzyme ligase, which is usually not present in the biosynthetic gene cluster. The terminal reductase domain (TD) and BogI-mediated valinol formation and their effect on the biological activity of bogorols are revealed. Succinylation, which is rarely reported in NRPs, was discovered in the bogorol family of peptides. We demonstrate that bogorols combat bacterial pathogens by forming pores in the cell membrane. We also report the synergistic effect of two natural products (relacidine B and bogorol K) produced by the same strain, which is relevant for competition for a niche.
What problem does this paper attempt to address?